๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Adjuvant therapy in colorectal cancer: The need for a mega-trial

โœ Scribed by I. Taylor; J. M. A. Northover

Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
196 KB
Volume
77
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The role of chemotherapy and adjuvant th
The role of chemotherapy and adjuvant therapy in the management of colorectal cancer
โœ Walter B. Forman ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 256 KB ๐Ÿ‘ 2 views

This review of the current literature related to the use of chemo-and adjuvant chemotherapy in colorectal carcinoma emphasizes the present dilemma in caring for people affected with this disorder. Adjuvant chemotherapy using combinations of 5-fluorouracil and levamisole clearly prolong survival, alb

Randomized clinical trial of adjuvant ra
Randomized clinical trial of adjuvant radiotherapy and 5-fluorouracil infusion in colorectal cancer (AXIS)
โœ The AXIS collaborators ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 182 KB ๐Ÿ‘ 2 views

## Abstract ## Background Postoperative portal vein infusion (PVI) of 5-fluorouracil (5-FU) is a well tolerated and widely applicable treatment for colorectal cancer that might have an enormous public health impact, even if it produced survival benefits of just a few per cent. Very large trials ar